AnalystsBenjamin HaynorBenjamin Haynor's Stock Forecasts
AnalystsBenjamin Haynor
Analyst Ranking
Top 43%
#2192 out of 5116 analysts
Average Return
+3.84%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Benjamin Haynor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viasat IncVSAT | +131.87% | $12.77 | $29.61 | 2024-09-20 - 2025-09-19 | Strong Buy |
Surmodics IncSRDX | +97.46% | $27.55 | $54.40 | 2017-06-27 - 2018-06-27 | Strong Buy |
Profound Medical CorpPROF | +40.72% | $4.69 | $6.60 | 2025-04-23 - 2025-11-28 | Strong Buy |
Electromed IncELMD | +8.07% | $24.77 | $26.77 | 2025-08-27 - 2025-11-28 | Strong Buy |
Benjamin Haynor Analyst Color
Get additional color on Benjamin Haynor's coverage of popular stocks
Benjamin Haynor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Infusystem Holdings IncINFU | 1 | Strong Buy | $15.00 | +61.64% | Assumes | 2 months ago |
Electromed IncELMD | 1 | Strong Buy | $36.00 | +34.48% | Assumes | 3 months ago |
Profound Medical CorpPROF | 1 | Strong Buy | $11.00 | +66.67% | Maintains | 7 months ago |
Viasat IncVSAT | 5 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Cognyte Software LtdCGNT | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Dariohealth CorpDRIO | 1 | Strong Buy | $1,400.00 | N/A | Initiates Coverage On | 8 years ago |
Surmodics IncSRDX | 1 | Strong Buy | $43.50 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.